Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand RJ Girbes, Pieter M ter Wee, AB Johan Groeneveld, for the CASH study group;Louise Schilder;S Azam Nurmohamed;Frank H Bosch;Ilse M Purmer;Sylvia S den Boer;Cynthia G Kleppe;Marc G Vervloet;Albertus Beishuizen;Armand RJ Girbes;Pieter M ter Wee;AB Johan Groeneveld;for the CASH study group;
critical care2014Vol. 18pp. -
168
group2014criticalcitrate
Abstract
Because of ongoing controversy, renal and vital outcomes are compared between systemically administered unfractionated heparin and regional anticoagulation with citrate-buffered replacement solution in predilution mode, during continuous venovenous hemofiltration ...